Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Questcor Pharmaceuticals (AMEX:QSC)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
3260 Whipple Road
Union City, CA 94587
Phone: (510) 400-0700
Fax: (510) 400-0799
Email: ir@questcor.com
Employees (last reported count): 46
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 37%
·Institutional: 16% (25% of float)
(16 institutions)
·Net Inst. Selling: 22.0K shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Questcor Pharmaceuticals Inc. is an integrated specialty pharmaceutical company focused on the development, acquisition and marketing of acute care and critical care hospital/specialty pharmaceutical products. The Company currently markets three products in the US: Glofil-125 and Inulin in Sodium Chloride, which are both injectable agents that assess kidney function by measuring glomerular filtration rate; and Ethamolin, an injectable drug used to treat esophageal varices that have recently bled. Additionally, the Company earns royalties from its strategic partner, Crinos Industria Farmacobiologica SpA on sales, in Italy, of Pramidin, an intranasal form of metoclopramide for the treatment of various gastrointestinal disorders.
More from Market Guide: Expanded Business Description

Financial Summary
Questcor Pharmaceuticals is an integrated specialty pharmaceutical company focused on the development, acquisition and marketing of acute care and critical care hospitality/specialty pharmaceutical products. For the six months ended 6/30/01, revenues rose 65% to $2 million. Net loss fell 57% to $3.9 million. Revenues reflect an increase in product sales of Ethamolin, Glofil, and Inulin. Lower loss also reflects lower development expenses for Emitasol.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Charles Casamento, 55
Chairman, Pres and CEO
$402K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:QSCAs of 31-Aug-2001
Price and Volume
52-Week Low
on 23-Apr-2001
$0.38 
Recent Price$1.18 
52-Week High
on 14-Sep-2000
$1.875
Beta0.15 
Daily Volume (3-month avg)66.0K
Daily Volume (10-day avg)52.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-30.1%
52-Week Change
relative to S&P500
-6.2%
Share-Related Items
Market Capitalization$44.0M
Shares Outstanding37.3M
Float23.5M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.03 
Earnings (ttm)-$0.34 
Earnings (mrq)-$0.07 
Sales (ttm)$0.17 
Cash (mrq)$0.18 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)6.92 
Income Statements
Sales (ttm)$4.40M
EBITDA (ttm)-$7.18M
Income available to common (ttm)-$8.63M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-53.75%
Return on Equity (ttm)-596.70%
Financial Strength
Current Ratio (mrq)1.04 
Debt/EquityN/A 
Total Cash (mrq)$6.75M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume124.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.